Deferred Tax Assets, Net of Valuation Allowance of Aspira Women's Health Inc. from 31 Dec 2011 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: Aspira Women's Health Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2011 to 31 Dec 2024.
Aspira Women's Health Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2024 was $285,000, a 132% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Aspira Women's Health Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$285,000	+$162,000	+132%	31 Dec 2024	10-K	27 Mar 2025	2024	FY
Q4 2023	$123,000			31 Dec 2023	10-K	27 Mar 2025	2024	FY
Q4 2020	$40,000			31 Dec 2020	10-K	31 Mar 2022	2021	FY
Q4 2014	$8,000	$0	0%	31 Dec 2014	10-K	30 Mar 2016	2015	FY
Q4 2013	$8,000	$0	0%	31 Dec 2013	10-K	31 Mar 2015	2014	FY
Q4 2012	$8,000	$0	0%	31 Dec 2012	10-K	31 Mar 2014	2013	FY
Q4 2011	$8,000			31 Dec 2011	10-K	01 Mar 2013	2012	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.